Developer docs
API playgroundTry for free, no card

Search company profiles

IRIS Global

Full company profile

uuid002gxn2

Namestring
IRIS Global
Websiteurl
irisgra.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

IRIS Global is a privately held pharmaceutical consulting services provider headquartered in Libertyville, Illinois. Founded in 2010, the firm operates with a small team of 1-10 employees and is registered as a for-profit entity. Its stated category positioning is as a consulting services provider serving the pharmaceutical sector, though specific service lines, therapeutic area expertise, and consulting frameworks are not disclosed in the available sources.

The company's public web presence is limited: its primary website (irisgra.com) and a related domain (irisglobalra.com) currently display verification or waiting pages, preventing extraction of detailed product, technology, or service portfolio information. No proprietary technology, platform architecture, analytical tooling, or service methodology is documented. There is no evidence of software product offerings, data assets, or technology-enabled delivery; the business model therefore appears to be human-delivered professional services rather than technology-enabled solutions.

As a private entity with no disclosed funding history, no investor relationships, no named customers, no public case studies, and no partnership arrangements, IRIS Global's revenue model, pricing mechanics, and go-to-market approach cannot be characterized from available data. The firm has not announced any acquisitions, leadership changes, product launches, or geographic expansions. Headcount of 1-10 employees places the firm in the boutique consulting tier, where revenue is typically derived from fee-for-service project billings, though no contract structure, rate card, or client engagement data is available to confirm this.

Short descriptiontext

IRIS Global is a privately held pharmaceutical consulting services provider founded in 2010 and headquartered in Libertyville, Illinois. Operating with 1-10 employees, the firm delivers specialized consulting services to pharmaceutical sector clients.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersQueen Creek, United States
HQ citystring
Queen Creek
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical consulting, regulatory affairs consulting, drug development consulting, life sciences consulting, pharma services
Industry1 code
PRIMARYBPAEAAAA
Strategy & IT Advisory
NAICS code2 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Consulting Services
Social media profiles2 records
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

IRIS Global is a pharmaceutical consulting services provider that delivers advisory and consulting support to clients in the pharmaceutical industry. The firm is privately held, founded in 2010, and operates with a small team (1-10 employees) out of Libertyville, Illinois, United States. Specific service lines, named practice areas, and client deliverables are not detailed in the available source material.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeDirect peer
Description

Global strategy consulting firm with a sizable life sciences and pharmaceuticals practice covering commercial strategy, M&A, and R&D portfolio work. Directly comparable on consulting business model and pharma buyer base.

TypeDirect peer
Description

Pharma and biotech-focused strategy consulting firm serving clients on commercial strategy, market access, and evidence generation. Closely mirrors the pharma-specialist boutique model.

TypeDirect peer
Description

Consulting firm with a Life Sciences practice advising pharma, biotech, and medtech clients on strategy, litigation, and regulatory matters. Comparable on pharma-focused management consulting service delivery and buyer profile.

4Trinity Partners
TypeDirect peer
Description

Life sciences consulting firm providing strategy, analytics, and commercialization support to pharma and biotech. Directly comparable as a specialist pharma consultancy of similar boutique scale.

TypeDirect peer
Description

Professional services firm with a Life Sciences practice advising pharma, biotech, and medical device clients on strategy, operations, and technology. Comparable on consulting model and pharma buyer base.

TypeBroad incumbent
Description

Global leader in life sciences services, technology, and consulting across pharma R&D, commercial, and real-world evidence. Represents the scaled incumbent that competes for large pharma engagements and ultimately acquires specialist capabilities.

7ZS Associates
TypeDirect peer
Description

Global management consulting firm with a dominant pharma and life sciences commercial practice, serving many of the same biopharma buyers IRIS Global would target. ZS represents the scaled, specialist pharma consultancy model that a growing boutique would compete against or eventually be acquired by.

TypeBroad incumbent
Description

Global consulting firm with a sizable Life Sciences practice serving pharma, medtech, and payer clients. Comparable as a broad incumbent competing for the same pharma consulting engagements.

TypeEmerging player
Description

Pharma-focused analytics and consulting firm serving commercial, sales, and marketing functions for global biopharma. Comparable on pharma specialization with a tech-enabled service model.

TypeDirect peer
Description

Specialist life sciences consulting firm focused on pharma and biotech commercial strategy, pricing, and market access. A direct comparable for a boutique pharma consultancy serving biopharma clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IRIS Global

Pharmaceutical Consulting Servicesirisgra.com

IRIS Global is a privately held pharmaceutical consulting services provider founded in 2010 and headquartered in Libertyville, Illinois. Operating with 1-10 employees, the firm delivers specialized consulting services to pharmaceutical sector clients.

What IRIS Global does

IRIS Global is a privately held pharmaceutical consulting services provider headquartered in Libertyville, Illinois. Founded in 2010, the firm operates with a small team of 1-10 employees and is registered as a for-profit entity. Its stated category positioning is as a consulting services provider serving the pharmaceutical sector, though specific service lines, therapeutic area expertise, and consulting frameworks are not disclosed in the available sources.

The company's public web presence is limited: its primary website (irisgra.com) and a related domain (irisglobalra.com) currently display verification or waiting pages, preventing extraction of detailed product, technology, or service portfolio information. No proprietary technology, platform architecture, analytical tooling, or service methodology is documented. There is no evidence of software product offerings, data assets, or technology-enabled delivery; the business model therefore appears to be human-delivered professional services rather than technology-enabled solutions.

As a private entity with no disclosed funding history, no investor relationships, no named customers, no public case studies, and no partnership arrangements, IRIS Global's revenue model, pricing mechanics, and go-to-market approach cannot be characterized from available data. The firm has not announced any acquisitions, leadership changes, product launches, or geographic expansions. Headcount of 1-10 employees places the firm in the boutique consulting tier, where revenue is typically derived from fee-for-service project billings, though no contract structure, rate card, or client engagement data is available to confirm this.

IRIS Global firmographics

Firmographics
Name
IRIS Global
Website
https://irisgra.com
Company type
Private
Founded year
2011
Headcount range
1–10 employees
Short description
IRIS Global is a privately held pharmaceutical consulting services provider founded in 2010 and headquartered in Libertyville, Illinois. Operating with 1-10 employees, the firm delivers specialized consulting services to pharmaceutical sector clients.
Ownership category
akta.pro rank

IRIS Global industry classification

Industry
Product category
Pharmaceutical Consulting Services
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAEAAAA
Strategy & IT Advisory

Keywords

  • Pharmaceutical consulting
  • Regulatory affairs consulting
  • Drug development consulting
  • Life sciences consulting
  • Pharma services

Where IRIS Global is headquartered

Location

Headquarters

HQ city
Queen Creek
HQ country
United States
HQ region
North America

Markets served

IRIS Global business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

IRIS Global product offering

Product offering

Core offering

IRIS Global is a pharmaceutical consulting services provider that delivers advisory and consulting support to clients in the pharmaceutical industry. The firm is privately held, founded in 2010, and operates with a small team (1-10 employees) out of Libertyville, Illinois, United States. Specific service lines, named practice areas, and client deliverables are not detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Companies that use IRIS Global

Customer profile

Ideal customer profiles1 record

IRIS Global technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

IRIS Global competitors and assessment

Company assessment

Direct peers

  • L.E.K. Consulting: Global strategy consulting firm with a sizable life sciences and pharmaceuticals practice covering commercial strategy, M&A, and R&D portfolio work. Directly comparable on consulting business model and pharma buyer base.
  • Putnam Associates: Pharma and biotech-focused strategy consulting firm serving clients on commercial strategy, market access, and evidence generation. Closely mirrors the pharma-specialist boutique model.
  • Charles River Associates: Consulting firm with a Life Sciences practice advising pharma, biotech, and medtech clients on strategy, litigation, and regulatory matters. Comparable on pharma-focused management consulting service delivery and buyer profile.
  • Trinity Partners: Life sciences consulting firm providing strategy, analytics, and commercialization support to pharma and biotech. Directly comparable as a specialist pharma consultancy of similar boutique scale.
  • Huron Consulting: Professional services firm with a Life Sciences practice advising pharma, biotech, and medical device clients on strategy, operations, and technology. Comparable on consulting model and pharma buyer base.
  • ZS Associates: Global management consulting firm with a dominant pharma and life sciences commercial practice, serving many of the same biopharma buyers IRIS Global would target. ZS represents the scaled, specialist pharma consultancy model that a growing boutique would compete against or eventually be acquired by.
  • ClearView Healthcare Partners: Specialist life sciences consulting firm focused on pharma and biotech commercial strategy, pricing, and market access. A direct comparable for a boutique pharma consultancy serving biopharma clients.

Broad incumbents

  • IQVIA: Global leader in life sciences services, technology, and consulting across pharma R&D, commercial, and real-world evidence. Represents the scaled incumbent that competes for large pharma engagements and ultimately acquires specialist capabilities.
  • Guidehouse: Global consulting firm with a sizable Life Sciences practice serving pharma, medtech, and payer clients. Comparable as a broad incumbent competing for the same pharma consulting engagements.

Emerging players

  • Axtria: Pharma-focused analytics and consulting firm serving commercial, sales, and marketing functions for global biopharma. Comparable on pharma specialization with a tech-enabled service model.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights4 records

Customer concentration

IRIS Global social profiles

Digital presence

IRIS Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IRIS Global leadership team

Management profile

Number of profiles

IRIS Global funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IRIS Global M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IRIS Global

What does IRIS Global do?

IRIS Global is a pharmaceutical consulting services provider that delivers advisory and consulting support to clients in the pharmaceutical industry. The firm is privately held, founded in 2010, and operates with a small team (1-10 employees) out of Libertyville, Illinois, United States. Specific service lines, named practice areas, and client deliverables are not detailed in the available source material.

When was IRIS Global founded?

IRIS Global was founded in 2011. It employs 1 to 10 people.

Where is IRIS Global based?

IRIS Global is headquartered in Queen Creek, United States, in the North America region.

Who are IRIS Global's main competitors?

Direct peers on record are L.E.K. Consulting, Putnam Associates, Charles River Associates, Trinity Partners, Huron Consulting, ZS Associates and ClearView Healthcare Partners. Broad incumbents are IQVIA and Guidehouse. Axtria is listed as an emerging player.

Does IRIS Global have an API?

No public API is recorded for IRIS Global.

What industry is IRIS Global in?

IRIS Global's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is BPAEAAAA, Strategy & IT Advisory. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales